Lifeward (NASDAQ:LFWD – Get Free Report) and Organigram Global (NASDAQ:OGI – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.
Profitability
This table compares Lifeward and Organigram Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lifeward | -123.66% | -243.14% | -97.39% |
| Organigram Global | 28.14% | -13.39% | -8.67% |
Risk and Volatility
Lifeward has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lifeward | $22.03 million | 0.96 | -$19.91 million | ($19.66) | -0.38 |
| Organigram Global | $309.18 million | 0.56 | -$17.70 million | $0.46 | 2.67 |
Organigram Global has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
26.8% of Lifeward shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Lifeward and Organigram Global, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lifeward | 1 | 1 | 1 | 0 | 2.00 |
| Organigram Global | 1 | 0 | 2 | 0 | 2.33 |
Lifeward currently has a consensus target price of $10.00, suggesting a potential upside of 34.23%. Given Lifeward’s higher possible upside, equities research analysts plainly believe Lifeward is more favorable than Organigram Global.
Summary
Organigram Global beats Lifeward on 11 of the 14 factors compared between the two stocks.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
